Jury 2012
Founder :
M. Roland MEHL, correspondant member of the National Academy of Pharmacy, membre of the New York Academy of Sciences.
Secretary general :
Mme Florence MEHL, communication and administration officer.
President :
Pr Charles CAULIN
Vice-President :
Pr Jean-Pierre REYNIER
Members
Pr Yves AGID, membre de l'Institut (Académie des Sciences), emeritus Professor of neurology, CHU Pitié Salpêtrière ( Pierre et Marie Curie university), member of the Comité consultatif national de l'Ethique.
Pr Jean-François BERGMANN, Head of department (Internal Medecine), Professor of Therapeutics at the Faculty of Medecine Paris VII, President of the Medical Devises and Drugs commission of AP-HP, Vice-President of the A.F.S.S.AP.S. A.M.M.commission.
Pr Claude BOHUON, Former Head of department (Clinical Biology) at Institut Gustave Roussy, Emeritus Professor of Immuno-Toxicology and Cancerogenesis at University Paris XI, Former President of the National Academy of Pharmacy.
Professor Jean-Pierre BOISSEL, Emeritus Professor of Clinical Pharmacology at the University Claude Bernard, Lyon, Founder President of the Institute of Theoretical Medicine, Chairman of the Ethics Committee of the International Agency for Research on Cancer.
Pr François BRICAIRE, Head of Infectious and Tropical Diseases department, Groupe Pitié-Salpetrière, member of the National Academy of Medicine.
Professor Eric BRUCKER, Head of the Metabolisme Endocrinology department, Chairman of the metabolic unit of exploration for the prevention of Cardiovascular disease, Groupe Hospitalier Pitie-Salpetriere.
Pr Jean CALOP, Chief Pharmacist at the University Hospital of Grenoble, Professor of Clinical Pharmacy Faculty of Pharmacy, Grenoble, member of the National Academy of Pharmacy.
Pr Charles CAULIN, Honorary Head of department (Internal Medicine) at Hôpital Lariboisière, Emeritus Professor of Therapeutics at Paris VII University, Former President of the A.F.S.S.AP.S. A.M.M.commission, Former President of the section of Conseil national des universités (Therapeutics).
Pr Michel DESNOS, Head of department (Clinical Cardiology) at Hôpital Européen Georges Pompidou, Professor of Cardiology at University Paris V, member of I.N.S.E.R.M. U 633 unit (Cells therapy for Cardiological pathologies), Former President of a working group of Société française de cardiologie.
Pr David KHAYAT, Head of the Ooncology department, Groupe Hospitalier Pitié-Salpêtrière, membre of conseil d'administration de l'INSERM, Founder President of Institut National du Cancer, O.MS. permanent under-secretary former counsellor in Geneva, Professor of medecine, Texas University.
Pr Claire LE JEUNNE, Head of Internal Medicine department, Broca Hospital Group, Cochin, Hôtel-Dieu, Professor of Therapeutic and Vice Dean for Education and Student life at the Faculty of Medicine Paris Descartes, former Vice-President of the Comité de transparence, H.A.S.
Pr Michel MARTY, President of the Center of Innovative Therapeutics in Oncology, Professor of Cancer desaeses at Paris-Est University.
Pr Jean-Pierre OLIE, Professor of Psychiatry at Universté Paris Descartes, Head of a depattment of Hôtal St Anne, Redactor in Chief of "l'Encéphale", President of Pierre Deniker Fondation, Member of the National Academy of Medicine.
Pr Philipe ORCEL, Head of the Rhumatoloy department Hôpital Lariboisière, teacher at Université de Paris VI / St Louis-Lariboisière, Secretary general at Société française de rhumatologie, Chairman of Collège français de médecine rhumatologique.
Pr Jean-Louis PRUGNAUD, Head of the Pharmacy department at Hôpital St Antoine, member of the National Academy of Pharmacy, member of the administration board of the Société française de Pharmacie clinique, Member of the A.F.S.S.AP.S. A.M.M.commission, Chairman of the genetic and cellular therapy commission.
Pr Jean REVUZ, Former Head of department (Dermatology) at Hôpital Henri-Mondor, Emeritus Professor of Dermatology at Paris XII university, Member of the A.F.S.S.AP.S. A.M.M.commission, President of the Cosmetology commission of A.F.S.S.A.P.S.
Pr Jean-Pierre REYNIER, Professor (Galenic Pharmacy) at Aix-Marseille University, Head of department, Member of the Executive Board of the European Drug Agency, Member of de National Academy of Pharmacy.
Honorary Members
Doyen Claude DREUX ; Prs Monique ADOLPHE, Marie-Germaine BOUSSER, Mireille BROCHIER, Frédérique KUTTENN, Catherine LEPORT, François CHAST, Georges CHEYMOL, Boyan CHRISTOFOROV, Yves COHEN, Jean COSTENTIN, Pierre DUCHENE-MARULLAZ, Françoise FORETTE, Xavier GIRERD, Jean-Paul GIROUD, Michel HAMON, François-Claude HUGUES, Jean-Louis IMBS, Christian JACQUOT, Claude JASMIN, André KAHAN, Géraud LASFARGUES, Henri LÔO, Marie-Madeleine LOUBATIÈRES, Jean-Louis MAS, Charles-Joël MENKÈS, François-Bernard MICHEL, Pierre POUILLART, Claude RAYBAUD, Georges SERRATRICE, Jean-Paul TILLEMENT, André VACHERON ; Dr Bernard PAUL- MÉTADIER.
In memoriam
Doyens Maurice-Marie JANOT, André QUEVAUVILLER, Guillaume VALETTE ; Prs Pierre BASTIDE, Jacques BOISSIER, Roger BOULU, Jean DRY, Jean-Albert GAUTIER, Charles HAAS, Claude LAROCHE, Paul LECHAT, Jean-Pierre LUTON, Jean MARCHE, Robert MOREAU, Antoine PUISSANT, Paul ROSSIGNOL, Henri SCHMITT, René TRUHAUT, Guy VOURC'H ; Drs Jean CAUFMENT, Jean COTTET, Henri NARGEOLET, Roger SARFATI, Pierre THEIL, François VACHON.
Honorary Committee
Pr Étienne-Émile BAULIEU
former president , French Academy of Sciences, National Academy of Sciences of U.S.A., Foreign Associate, professor at Collège de France, adjunct professor, Scripps Institute, U.S.A.
Pr Gunther BÖBEL
Nobel prize (medicine)
Pr Pierre CHAMBON
Prix Lasker, member of the Institut de France (Academy of Sciences) and of the National Academy of SciencesU.S., founder of the Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGNMC), honorary professor at Collège de France.
Pr Jean-Pierre CHANGEUX
member of Institut de France (Academy of Sciences), emeritus professor at Collège de France and at Institut Pasteur.
Doyen Claude DREUX
honorary dean of the faculty of pharmaceutical studies, former president de National Academy of Pharmacy, member of the National Academy of Medicine.
Pr François GROS
member of Institut de France (honorary permanent secretary of the Academy of Sciences), honorary professor at Collège de France and at Institut Pasteur.
Pr François JACOB
Nobel prize (medicine), membre of Institut de France (Académie française, Academy of Sciences), honorary professor at Collège de France and at Institut Pasteur.
M. Pierre JOLY
president of the National Academy of Medicine, honorary president of the Foundation for Medical Research, former president of the National Academy of Pharmacy.
M. Bernard MESURÉ
honorary member of LEEM Research, honorary president of LEEM.
M. Fernand SAUER
former executive director of the European Drug Agency, director in charge of health issues at the European Commission.
Pr Manuel DIAZ-RUBIO GARCIA
president of the Spanish Royal Academy of Medicine.
Pr André SYROTA
director general (INSERM), university professor, hospital practitioner.
Pr André VACHERON
former president of the National Academy of Medicine, correspondant of Institut de France,honorary president of the French Federation of Cardiology and former president of the French Society of Cardiology.
Sir John VANE
Nobel prize (medicine), Lasker prize, honorary professor at Yale university and King's College, London.
Pr Elie WIESEL
Nobel prize (Peace), honorary professor at Boston university, president of the Universal of Cultures Academy and th Humanity Foundation.
In memoriam
Pr Jean BERNARD, Pr Jean DAUSSET, Pr Pierre POTIER, Pr Michael SMITH, Sir John VANE
Winners
- 2011
-
- Tolicizumab (Roactemra, Roche-Chugaï)
- Fibrinogène humain (Clottafact, LFB)
- Vaccin Ixiaro (Novartis Vaccines)
- 2010
-
- Rivaroxaban (Xarelto, Bayer Schering Pharma)
- Azacitine (Vidaza, Celgene)
- Romiplostim (Nplate,Amgen)
- 2009
-
- Natalizumab (Tysabri, Biogen Idec).
- Eculizumab (Soliris, Alexion Pharma France).
- Pr Couvreur (UMR CNRS 8612, université Paris Sud) pour ses travaux sur la squalénisation
- 2008
-
- Ivabradine (Procoralan, institut de recherches internationales Servier).
- Raltégravir (Isentress, Merck Sharp & Dohme /Chibret).
- Sorafénib (Nexavar, Bayer-Shering Pharma).
- Stiripentol (Diacomit, Biocodex).
- 2007
-
- Vaccin anti-papillomavirus (Gardasil, Sanofi-Pasteur-M.S.D.)
- Cétuximab (Erbitux, Merck Lipha)
- Pr Guillouzo (INSERM et faculté de Rennes) pour ses travaux sur les hépatocytes.
- 2006
-
- Aripiprazole (Abilify, Bristol-Myers Squibb-Otsuka Pharmaceutical France)
- Bevacizumab (Avastin, Roche)
- 2005
-
- Ranélate de strontium (Protélos, Servier).
- Bortézomide (Velcade, Janssen-Cilag).
- Service de Santé des Armées, pour la prise en charge des intoxications par les neurotoxiques organophosphorés.
- 2004
-
- Oxaliplatine (Eloxatine, Sanofi-Snthélabo).
- Bosentan (Tracleer, Actélion Pharmaceuticals France).
- Groupe Ipsen.
- 2003
-
- Polyoside pnemococcique (Prevenar, Wyeth).
- Voriconazole (Vfend, Pfizer).
- 2002
-
- Imatinib (Glivec, Novartis).
- Institut de recherches internationales Servier.
- 2001
-
- Vertéporfine (Visudyne, Novartis).
- Méthyl-pyrazole (Fomépizole, APHP-Orphan).
- Pr Schwartz (INSERM) pour l'identification de nouvelles cibles pharmacologiques.
- 2000
-
- Sildénafil (Viagra, Pfizer) et Clopidogrel (Plavix, Sanofi-Synthélabo, BMS).
- Centre de recherches de Val-de-Reuil (Janssen-Cilag).
- 1999
-
- Rituximab (Mabthera, Roche).
- Pr Fruchart (Institut Pasteur, INSERM et faculté de Lille) pour ses recherches sur les lipoprotéines.
- 1998
-
- Interféron-bêta-1a (Avonex, Biogen) et Follitropine (Purégon, Organon et Gonal-F, Sérono).
- Institut de recherche Pierre Fabre.
- 1997
-
- Modafinil (Modiodal, Lafon).
- Pr Roques (INSERM-CNRS) pour la modélisation de nouvelles molécules.
- 1996
-
- Rispéridone (Risperdal, Janssen-Cilag).
- Drs Brelière et Maffrand (Sanofi) pour leurs travaux sur les neuropeptides.
- 1995
-
- Lidocaïne-Prilocaïne (Emla, Astra).
- Pr Bousquet (Faculté et CNRS de Strasbourg) pour ses travaux sur les récepteurs aux imidazolines.
- 1994
-
- Vaccins pentavalents (Pentacoq, Mérieux - Pent-Hibest, Pasteur).
- Pr Potier (CNRS) pour l'ensemble de ses travaux en thérapeutique oncologique.
- 1993
-
- Vaccin antihépatite A (Havrix, SK-Beecham).
- Equipes de recherche Synthélabo pour l'ensemble de leurs travaux.
- 1992
-
- Filgrastim (Neupogen, Amgen-Roche).
- Dr Junien et l'Institut de recherche Jouveinal.
- 1991
-
- Octréotide (Sandostatine, Sandoz).
- Equipe de recherche Lafon pour l'ensemble de ses découvertes.
- 1990
-
- Simvastatine (Zocor, MSD-Chibret).
- Laboratoire Guerbet pour le secteur innovant de ses produits.
- Pr Puisieux (CNRS) pour ses travaux sur la vectorisation des médicaments.
- 1989
-
- Rt-PA (Actilyse, Boehringer Ingelheim).
- Dr Dubertret (INSERM) pour son étude du mécanisme d'action des antipsoriasiques.
- 1988
-
- Flumazénil (Anexate, Roche).
- Dr Braquet (Institut Beaufour) pour ses travaux sur les antagonistes du PAF.
- 1987
-
- Praziquantel (Biltricide, Bayer et Cénaride, Merck-Clévenot).
- Drs Arcan, Blanchard et M. Panak, (Millot-Solac) pour la recherche et le développement de la ticlopidine.
- 1986
-
- Amoxicilline/acide clavulanique (Augmentin, Beecham-Sévigné).
- Drs Choay, Lormeau et Petitou, Institut Choay pour leurs travaux sur l'héparine et ses fragments dans la maladie thrombo-embolique.
- 1985
-
- Aciclovir (Zovirax, Wellcome).
- Pr Montagnier (Institut Pasteur) pour la découverte du virus LAV.
- 1984
-
- Ciclosporine (Sandimmun, Sandoz) et Etrétinate (Tigason, Roche).
- 1983
-
- Captopril (Lopril, Squibb).
- MM. Uzan et Le Fur (Pharmuka) pour leurs travaux sur l'indalpine.
- 1982
-
- Inosine-acédobène-dimépramol (Isoprinosine, Delalande).
- M. Bush (Riom, laboratoires Cerm) pour ses travaux sur le tiémonium et ses dérivés.
- 1981
-
- Naloxone (Narcan, Winthrop).
- Pr Maupas (Faculté de Tours) pour le vaccin antihépatite B.
- 1980
-
- Nifédipine (Adalate, Bayer).
- Dr Laubie (Servier) pour ses travaux sur l'almitrine.
- 1979
-
- Cimétidine (Tagamet, SKF).
- Dr Le Douarec (MSD) pour ses travaux sur le timolol.
- 1978
-
- Bromocriptine (Parlodel, Sandoz).
- Acide tiénilique (Diflurex, Albert-Rolland) et lévamisole (Solaskil, Specia).
- 1977
-
- Fénofibrate (Lipanthyl, Fournier).
- 1976
-
- Vaccin antiméningococcique (Institut Mérieux).
- MM. Thominet, Laville, Mlle Margarit (Delagrange) pour la mise au point du sulpiride et de la métoclopramide.
- 1975
-
- Acide chénodésoxycholique (Chénodex, Houdé).
- 1974
-
- Lévodopa (et carbidopa : Sinemet, MSD-Chibret ; et bensérazide : Modopar, Roche).
- 1973
-
- Kétoprofène (Profénid, Specia).
- Dr Hannoun (Institut Pasteur) pour le vaccin mutant antigrippal.
- 1972
-
- Clofibrate (Lipavlon, ICI-Pharma).
- Dr Maral, MM. Jollès et Ponsinet (Rhône-Poulenc) pour la synthèse des dérivés hémisynthétiques de la daunorubicine.
- 1971
-
- Cromoglycate disodique (Lomudal, Fisons).
- Dr Martel (Roussel) pour la synthèse directe de la prostaglandine A2.
- 1970
-
- Rifampicine (Rifadine, Lepetit ; Rimactan, Ciba).

